INCY Incyte Corporation - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q जुल 28, 2026
$115.30
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$82.8252w निम्न
$132.6052w उच्च
मार्केट कैप (MRQ)
$23.17B
P/E (TTM)
14.7
EPS (TTM)
$7.85
राजस्व (TTM)
$5.82B
आपके बैज
52W रेंज
$83–$133
विश्लेषक रेटिंग
HOLD
मूल्य लक्ष्य
$128
P/E
14.7
ROE
30.7%
शुद्ध लाभ मार्जिन
27.7%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
INCY स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$115.30
मार्केट कैप (MRQ)
$23.17B
P/E (TTM)
14.7
EPS (TTM)
$7.85
राजस्व (TTM)
$5.82B
ROE (TTM)
30.7%
52W रेंज
$83–$133
INCY स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
स्टॉक विभाजन
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 1 सितमबर 2000 | 2-for-1 | फॉरवर्ड |
| 10 नवमबर 1997 | 2-for-1 | फॉरवर्ड |
Incyte Corporation - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
History
Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993. Subsequently, scientists and chemists were recruited from DuPont to work for Incyte. Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.
In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014. Hervé Hoppenot became CEO in January 2014.
In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.
In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021. The company expanded its Delaware headquarters, including the addition of a research and development facility, in 2022. Incyte acquired Villaris Therapeutics in 2022, and Escient Pharmaceuticals in 2024.
For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income. Incyte is publicly traded on the NASDAQ under the symbol INCY. Incyte now operates out of North America, Asia, and Europe. Bill Meury became CEO in 2025. Meury replaced Hoppenot, who retired after 11 years in the position.
Pharmaceuticals
Incyte Corporation currently has seven marketed and co-marketed pharmaceutical products, including Jakafi (ruxolitinib), Pemazyre (pemigatinib), Monjuvi (tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib).
In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib (INC280, INCB028060), which is marketed under the brand name Tabrecta.
As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis under the brand name Olumiant.
As of 2016 epacadostat, an indoleamine 2,3-dioxygenase (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab (Keytruda) and Bristol Myers Squibb's nivolumab (Opdivo).
Acquisition history
Incyte has made a total of 3 acquisitions.
Maxia Pharmaceuticals (2003): An early acquisition in Incyte's history, the company purchased Maxia in 2003 for $42 million.
Villaris Therapeutics (2022): This acquisition was valued at approximately $1.4 billion and included an upfront payment along with milestones. It added new assets to Incyte's portfolio for treating vitiligo and other autoimmune conditions.
Escient Pharmaceuticals (2024): In May 2024, Incyte acquired this San Diego-based, clinical-stage company for $750 million. The acquisition provided Incyte with two oral drug candidates for inflammatory diseases, EP262 and EP547.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी2844
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$5.14B2016-12-31 → 2025-12-31
EPS$6.412016-12-31 → 2025-12-31
फ्री कैश फ्लो·2017-12-31 → 2022-12-31
शुद्ध मार्जिन27.7%2018-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | INCY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 14.75Y औसत ≈113.9 | ≈113.9 | 22.0 | अल्पमूल्यित | |
| P/S (TTM) | 4.05Y औसत ≈4.4 | ≈4.4 | 7.3 | अल्पमूल्यित | |
| P/B (MRQ) | 3.75Y औसत ≈4.0 | ≈4.0 | 6.1 | अल्पमूल्यित | |
| Price / Cash Flow (मूल्य / नकदी प्रवाह) | 16.25Y औसत ≈23.5 | ≈23.5 | 13.9 | उचित मूल्य | |
| Price / Tangible Book (मूल्य / मूर्त पुस्तक) | 4.55Y औसत ≈3.9 | ≈3.9 | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | INCY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 30.6%5Y औसत ≈16.9% | ≈16.9% | 16.9% | शीर्ष स्तर | |
| EBITDA मार्जिन (TTM) | 32.2%5Y औसत ≈18.9% | ≈18.9% | 15.8% | शीर्ष स्तर | |
| प्रीटैक्स मार्जिन (TTM) | 33.8%5Y औसत ≈18.6% | ≈18.6% | 9.3% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | 27.7%5Y औसत ≈16.9% | ≈16.9% | 12.7% | शीर्ष स्तर | |
| ROA (TTM) | 23.5%5Y औसत ≈12.5% | ≈12.5% | 6.8% | शीर्ष स्तर | |
| ROE (TTM) | 30.7%5Y औसत ≈16.0% | ≈16.0% | 18.7% | शीर्ष स्तर | |
| ROIC | 22.7%5Y औसत ≈14.3% | ≈14.3% | 16.4% | शीर्ष स्तर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | INCY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 4.65Y औसत ≈3.1 | ≈3.1 | 3.1 | मजबूत तरलता | |
| Quick Ratio (त्वरित अनुपात) | 2.05Y औसत ≈2.0 | ≈2.0 | 1.7 | मजबूत तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | INCY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 21.2%5Y औसत ≈14.1% | ≈14.1% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 14.8%5Y औसत ≈12.9% | ≈12.9% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 14.0% | · | · | · | |
| EPS YoY | 4173.3%5Y औसत ≈1022.2% | ≈1022.2% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 3845.0%5Y औसत ≈940.4% | ≈940.4% | · | · | |
| EPS CAGR 3Y | 61.6% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | 55.7% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | INCY | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.85Y औसत ≈0.7 | ≈0.7 | 0.7 | शीर्ष स्तर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 4.75Y औसत ≈5.6 | ≈5.6 | 1.9 | शीर्ष स्तर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$1.8M | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
19.2%
अगली रिपोर्ट
अक्ट 26, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | जुल 27, 2026 | $3.09 | $2.14 | 44.1% |
| 31 मार्च 2026 | $1.81 | $1.40 | 29.4% | |
| 31 दिसमबर 2025 | $1.80 | $1.97 | -8.5% | |
| 30 सितमबर 2025 | $2.26 | $1.69 | 33.7% | |
| 30 जून 2025 | $1.57 | $1.50 | 4.7% | |
| 31 मार्च 2025 | $1.16 | $1.04 | 11.9% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Cost of Revenue | $372M | $312M | $255M | $207M | $151M | $131M | $114M | $94M | $79M | $58M | $27M | $3M | |
| R&D Expense | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B | $1.33B | $582M | $480M | $348M | |
| SG&A Expense | $1.38B | $1.24B | $1.16B | $1.00B | $740M | $517M | $469M | $434M | $366M | $303M | $197M | $166M | |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B | $1.78B | $961M | $703M | $516M | |
| Operating Income | $1.51B | $61M | $621M | $579M | $586M | $-264M | $402M | $129M | $-243M | $145M | $51M | $-5M | |
| Interest Expense | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $7M | $39M | $46M | $47M | |
| Interest Income | $106M | $129M | $158M | $40M | · | · | · | · | · | · | · | · | |
| Other Non-op | $25M | $13M | $14M | $-519.0K | $11M | $23M | $52M | $32M | $17M | · | · | · | |
| Pretax Income | $1.66B | $317M | $834M | $529M | $570M | $-232M | $487M | $115M | $-312M | $107M | $8M | $-49M | |
| Income Tax | $378M | $284M | $237M | $188M | $-378M | $63M | $40M | $6M | $852.0K | $3M | $1M | $-66.0K | |
| Net Income | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | $-1.36 | $2.08 | $0.52 | $-1.53 | $0.55 | $0.04 | $-0.29 | |
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 | |
| Shares (Basic) | 195,204,000 | 207,110,000 | 223,628,000 | 222,004,000 | 220,428,000 | 218,073,000 | 214,913,000 | 212,383,000 | 204,580,000 | 187,873,000 | 179,601,000 | 167,947,000 | |
| Shares (Diluted) | 200,700,000 | 210,530,000 | 225,928,000 | 223,958,000 | 222,074,000 | 218,073,000 | 217,657,000 | 215,635,000 | 204,580,000 | 194,125,000 | 187,302,000 | 167,947,000 | |
| EBITDA | $1.61B | $151M | · | $647M | $644M | $-212M | $457M | $184M | $-192M | · | · | $37M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B | $1.51B | $1.83B | $1.16B | $900M | $652M | $521M | $452M | |
| Short-term Investments | · | · | · | · | · | · | $285M | $274M | $270M | $156M | $186M | $148M | |
| Inventory | $101M | $59M | $63M | $42M | $28M | $16M | $11M | $7M | $6M | $4M | $2M | $358.0K | |
| Prepaid Expense | $318M | $169M | $183M | $167M | $126M | $60M | $44M | $79M | $62M | $33M | $18M | $21M | |
| Current Assets | $5.02B | $3.24B | $4.65B | $4.09B | $3.12B | $2.36B | $2.48B | $1.83B | $1.50B | $994M | $842M | $680M | |
| PP&E (Net) | $731M | $763M | $752M | $739M | $724M | $560M | $378M | $320M | $260M | $168M | $86M | $82M | |
| PP&E (Gross) | $1.11B | $1.09B | $1.02B | $952M | $900M | $704M | $499M | $423M | $334M | $219M | $131M | $116M | |
| Accum. Depreciation | $375M | $328M | $270M | $213M | $176M | $144M | $122M | $103M | $75M | $52M | $45M | $35M | |
| Goodwill | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $237M | $270M | $12M | $2M | |
| Other Non-current Assets | $18M | $11M | $52M | $25M | $37M | $39M | $49M | $19M | $2M | $3M | $12M | · | |
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Accounts Payable | $210M | $197M | $110M | $278M | $172M | $99M | $84M | $104M | $68M | $76M | $30M | $24M | |
| Accrued Liabilities | $1.03B | $1.21B | $936M | $701M | $534M | $378M | $286M | $229M | $199M | $127M | $87M | $62M | |
| Current Liabilities | $1.52B | $1.64B | $1.24B | $1.16B | $854M | $631M | $513M | $425M | $375M | $274M | $168M | $221M | |
| Capital Leases | $15M | $17M | $14M | $14M | $16M | $14M | $12M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $20M | |
| Other Non-current Liabilities | $165M | $168M | $149M | $99M | $70M | $58M | $40M | $22M | $20M | $13M | $48M | $55M | |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B | $950M | $828M | $720M | $672M | $1.22B | $836M | $878M | |
| Long-term Debt | · | · | · | · | · | · | · | $19.09B | $27M | $750M | $750M | $841M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $689M | |
| Common Stock | $198.0K | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K | $216.0K | $213.0K | $211.0K | $189.0K | $187.0K | $171.0K | |
| Retained Earnings | $214M | $-1.07B | $160M | $-437M | $-778M | $-1.73B | $-1.43B | $-1.88B | $-1.99B | $-1.67B | $-1.78B | $-1.79B | |
| AOCI | $25M | $-13M | $13M | $15M | $-19M | $-15M | $-16M | $-10M | $-7M | $-3M | $-809.0K | $2M | |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B | $2.61B | $2.60B | $1.93B | $1.63B | $419M | $171M | $-82M | |
| Liabilities + Equity | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Shares Outstanding | 198,460,009 | 193,434,305 | 224,286,862 | 222,746,719 | 221,084,433 | 219,489,329 | 216,177,830 | 213,274,660 | 211,262,906 | 188,848,752 | 186,650,249 | 170,876,619 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $93M | $89M | $83M | $68M | $58M | $52M | $55M | $55M | $52M | $58M | $45M | $41M | |
| Stock-based Comp | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M | $70M | $62M | |
| Deferred Tax | $248M | $-86M | $-159M | $57M | $-466M | $-350.0K | $-377.0K | $-459.0K | $-805.0K | · | · | · | |
| Amort. of Intangibles | $27M | $24M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $13M | · | · | |
| Other Non-cash | $-463M | $33M | · | $316M | $26M | $-58M | $43M | $24M | · | · | · | · | |
| Operating Cash Flow | $1.41B | $335M | $496M | $970M | $749M | $-125M | $711M | $336M | $-93M | $305M | $89M | $26M | |
| CapEx | · | · | · | $78M | $181M | $187M | $78M | $73M | $111M | $120M | $26M | $28M | |
| Investing Cash Flow | $-103M | $158M | $-208M | $-79M | $-208M | $-269M | $-87M | $-86M | $-350M | $-232M | $-105M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $649M | · | · | · | |
| Stock Repurchased | $0 | $2.00B | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-2.00B | · | · | · | · | · | · | $649M | · | · | · | |
| Financing Cash Flow | $101M | $-2.02B | $-20M | $-794.0K | $6M | $72M | $46M | $15M | $690M | $45M | $85M | · | |
| Net Change in Cash | $1.41B | $-1.53B | $262M | $894M | $544M | $-319M | $669M | $265M | $247M | $117M | $69M | $-19M | |
| Taxes Paid | $212M | $373M | $378M | $136M | $68M | $71M | $34M | $5M | $6M | $927.0K | · | · | |
| Free Cash Flow | · | · | · | $892M | $568M | $-312M | $633M | $263M | $-204M | · | · | $-2M | |
| Levered FCF | · | · | · | $890M | $565M | $-315M | $631M | $261M | $-211M | · | · | $-48M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.5% | 1.5% | · | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.9% | · | · | -0.94% | |
| Net Margin | 25.0% | 0.77% | · | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | · | · | · | · | |
| Pretax Margin | 32.4% | 7.5% | · | 15.6% | 19.1% | -8.7% | 22.6% | 6.1% | -20.3% | · | · | -9.5% | |
| EBITDA Margin | 31.3% | 3.5% | · | 19.1% | 21.6% | -7.9% | 21.1% | 9.8% | -12.5% | · | · | 7.2% | |
| ROA | 20.8% | 0.53% | · | 6.3% | 22.3% | -8.5% | 14.7% | 4.4% | · | · | · | · | |
| ROE | 27.6% | 0.99% | · | 7.9% | 27.4% | -11.8% | 17.8% | 5.9% | · | · | · | · | |
| ROIC | 22.7% | 0.18% | · | 8.5% | 25.8% | -12.9% | 14.2% | 6.4% | -15.0% | · | · | -0.79% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.0 | · | 3.5 | 3.7 | 3.7 | 4.8 | 4.3 | 4.0 | · | · | 3.2 | |
| Quick Ratio | 2.0 | 1.0 | · | 2.6 | 2.4 | 2.4 | 4.1 | 3.4 | 3.1 | · | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | -8.4 | |
| Interest Coverage | · | · | · | 217.3 | 307.0 | -121.3 | 216.7 | 83.7 | -35.3 | · | · | -0.1 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | 0.7 | |
| Inventory Turnover | 4.7 | 5.1 | · | 5.9 | 6.8 | 9.4 | 12.4 | 14.0 | 15.0 | · | · | 7.9 |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $26.04 | $17.82 | · | $19.62 | $17.05 | $11.90 | $12.02 | $9.03 | $7.72 | · | · | · | |
| Revenue / Share | $25.62 | $20.15 | · | $15.16 | $13.45 | $12.23 | $9.92 | $8.73 | $7.51 | · | · | · | |
| Cash Flow / Share | $7.04 | $1.59 | · | $4.33 | $3.37 | $-0.57 | $3.27 | $1.56 | $-0.45 | · | · | · | |
| Cash / Share | $15.61 | $8.73 | · | $13.25 | $9.31 | $6.89 | $8.48 | $5.46 | $4.26 | · | · | · | |
| EPS (TTM) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 12.4% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4173.3% | -94.3% | 74.3% | -64.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 61.6% | -67.2% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3845.0% | -94.5% | 75.4% | -64.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 55.7% | -67.5% | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Net Income TTM | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| Market Cap | $19.60B | $13.36B | · | $17.89B | $16.23B | $19.09B | $18.88B | $13.56B | $20.01B | · | · | · | |
| P/E | 15.4 | 460.5 | 23.7 | 52.8 | 17.2 | -64.0 | 42.6 | 124.7 | -61.9 | 185.7 | 3615.0 | -252.1 | |
| P/S | 3.8 | 3.2 | · | 5.3 | 5.4 | 7.2 | 8.7 | 7.2 | 13.0 | · | · | · | |
| P/B | 3.8 | 3.9 | · | 4.1 | 4.3 | 7.3 | 7.3 | 7.0 | 12.3 | · | · | · | |
| P / Tangible Book | 3.9 | 4.1 | 2.8 | 4.2 | 4.5 | 7.8 | · | · | · | · | · | · | |
| P / Cash Flow | 13.9 | 39.8 | · | 18.4 | 21.7 | -153.2 | 26.6 | 40.3 | -215.2 | · | · | · | |
| P / FCF | · | · | · | 20.1 | 28.5 | -61.2 | 29.8 | 51.6 | -98.1 | · | · | · | |
| Earnings Yield | 6.5% | 0.22% | 4.2% | 1.9% | 5.8% | -1.6% | 2.4% | 0.80% | -1.6% | 0.54% | 0.03% | -0.40% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | $1.05B | $1.18B | $1.14B | $1.04B | $881M | $1.01B | $919M | $955M | $809M | $927M | $823M | |
| Cost of Revenue | $105M | $105M | $121M | $99M | $79M | $73M | $88M | $86M | $77M | $61M | $70M | $60M | $68M | $57M | $59M | $55M | |
| R&D Expense | $517M | $516M | $611M | $507M | $495M | $437M | $466M | $573M | $1.14B | $429M | $444M | $376M | $401M | $407M | $501M | $384M | |
| SG&A Expense | $352M | $328M | $390M | $329M | $331M | $326M | $327M | $309M | $306M | $300M | $288M | $268M | $284M | $316M | $273M | $266M | |
| Operating Expenses | $976M | $972M | $1.17B | $922M | $685M | $848M | $877M | $992M | $1.52B | $789M | $826M | $704M | $761M | $784M | $857M | $685M | |
| Operating Income | $698M | $301M | $336M | $444M | $530M | $205M | $302M | $146M | $-478M | $92M | $187M | $215M | $194M | $25M | $70M | $138M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $430.0K | · | $623.0K | $655.0K | $469.0K | · | $641.0K | |
| Interest Income | $38M | $34M | $31M | $27M | $25M | $23M | $21M | $19M | $41M | $47M | · | · | · | · | · | · | |
| Other Non-op | $6M | $3M | $6M | $4M | $7M | $8M | $2M | $5M | $8M | $-2M | $-108M | $46M | $43M | $33M | $-14M | $12M | |
| Pretax Income | $752M | $344M | $390M | $482M | $558M | $234M | $314M | $157M | $-390M | $236M | $271M | $234M | $278M | $52M | $81M | $149M | |
| Income Tax | $166M | $40M | $91M | $58M | $153M | $76M | $113M | $50M | $55M | $67M | $70M | $63M | $74M | $30M | $52M | $36M | |
| Net Income | $586M | $303M | $299M | $424M | $405M | $158M | $201M | $106M | $-445M | $170M | $201M | $171M | $204M | $22M | $28M | $113M | |
| EPS (Basic) | $2.92 | $1.52 | $1.51 | $2.17 | $2.09 | $0.82 | $0.89 | $0.55 | $-2.04 | $0.76 | $0.90 | $0.76 | $0.91 | $0.10 | $0.12 | $0.51 | |
| EPS (Diluted) | $2.81 | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.90 | $0.54 | $-2.04 | $0.75 | $0.89 | $0.76 | $0.90 | $0.10 | $0.13 | $0.50 | |
| Shares (Basic) | 200,378,000 | 199,343,000 | · | 195,670,000 | 193,995,000 | 193,712,000 | · | 192,629,000 | 218,175,000 | 224,484,000 | · | 224,078,000 | 223,248,000 | 222,960,000 | · | 222,415,000 | |
| Shares (Diluted) | 208,216,000 | 206,830,000 | · | 201,429,000 | 198,744,000 | 198,197,000 | · | 195,838,000 | 218,175,000 | 227,219,000 | · | 226,167,000 | 225,649,000 | 225,589,000 | · | 224,175,000 | |
| EBITDA | $698M | $325M | · | $444M | $530M | $228M | · | $146M | $-478M | $114M | · | $215M | $194M | $44M | · | $138M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | $1.94B | $1.69B | $1.30B | $987M | $3.35B | · | $3.23B | $3.13B | $2.82B | · | $2.69B | |
| Inventory | $113M | $116M | $101M | $83M | $83M | $64M | $59M | $70M | $101M | $64M | · | $57M | $36M | $41M | · | $46M | |
| Prepaid Expense | $253M | $301M | $318M | $369M | $296M | $212M | $169M | $205M | $208M | $189M | · | $172M | $167M | $194M | · | $180M | |
| Current Assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | $3.51B | $3.24B | $2.81B | $2.57B | $4.85B | · | $4.40B | $4.26B | $3.97B | · | $3.82B | |
| PP&E (Net) | $709M | $720M | $731M | $799M | $799M | $765M | $763M | $773M | $762M | $720M | · | $733M | $749M | $742M | · | $716M | |
| PP&E (Gross) | $1.11B | $1.11B | $1.11B | $1.16B | $1.14B | $1.11B | $1.09B | $1.09B | $1.06B | $1.00B | · | $986M | $988M | $967M | · | $918M | |
| Accum. Depreciation | $404M | $389M | $375M | $361M | $346M | $344M | $328M | $316M | $298M | $283M | · | $253M | $239M | $226M | · | $202M | |
| Goodwill | $133M | $133M | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | $156M | $156M | $156M | · | $156M | |
| Other Non-current Assets | $87M | $24M | $18M | $32M | $33M | $30M | $11M | $40M | $22M | $47M | · | $81M | $32M | $21M | · | $24M | |
| Total Assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Accounts Payable | $250M | $229M | $210M | $172M | $241M | $196M | $197M | $179M | $148M | $164M | · | $139M | $156M | $56M | · | $163M | |
| Accrued Liabilities | $870M | $1.09B | $1.03B | $948M | $857M | $1.38B | $1.21B | $1.13B | $1.03B | $1.10B | · | $821M | $811M | $825M | · | $700M | |
| Current Liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | $1.72B | $1.64B | $1.50B | $1.34B | $1.40B | · | $1.12B | $1.12B | $1.01B | · | $1.01B | |
| Capital Leases | · | · | $15M | · | · | · | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $125M | $127M | $165M | $171M | $180M | $176M | $168M | $145M | $142M | $151M | · | $133M | $140M | $118M | · | $75M | |
| Total Liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | $2.08B | $2.00B | $1.84B | $1.66B | $1.74B | · | $1.46B | $1.47B | $1.34B | · | $1.28B | |
| Common Stock | $201.0K | $200.0K | $198.0K | $196.0K | $194.0K | $193.0K | $193.0K | $192.0K | $191.0K | $224.0K | · | $224.0K | $223.0K | $223.0K | · | $222.0K | |
| Retained Earnings | $1.10B | $517M | $214M | $-86M | $-510M | $-915M | $-1.07B | $-1.27B | $-1.38B | $330M | · | $-41M | $-212M | $-416M | · | $-466M | |
| AOCI | $20M | $22M | $25M | $15M | $13M | $-6M | $-13M | $16M | $-5M | $-6M | · | $23M | $27M | $21M | · | $-29M | |
| Stockholders' Equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | $3.67B | $3.45B | $3.17B | $3.00B | $5.39B | $5.19B | $4.93B | $4.74B | $4.46B | $4.37B | $4.23B | |
| Liabilities + Equity | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Shares Outstanding | 200,977,687 | 199,948,401 | 198,460,009 | 196,130,993 | 194,123,265 | 193,783,446 | 193,434,305 | 192,798,328 | 191,572,449 | 224,533,449 | · | 224,101,839 | 223,338,330 | 223,061,787 | · | 222,454,839 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $24M | $23M | $22M | $23M | $23M | $22M | $22M | $22M | $21M | $20M | $19M | $18M | $17M | |
| Stock-based Comp | $67M | $64M | $62M | $62M | $65M | $61M | $72M | $78M | $57M | $60M | $60M | $48M | $55M | $53M | $53M | $45M | |
| Other Non-cash | · | $-22M | · | · | · | $25M | · | · | · | $-32M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $508M | $369M | $543M | $559M | $45M | $266M | $381M | $311M | $-576M | $219M | $148M | $148M | $307M | $-106M | $284M | $296M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Investing Cash Flow | $-52M | $-88M | $-37M | $-47M | $-19M | $1M | $-21M | $38M | $214M | $-73M | $-154M | $-17M | $-7M | $-29M | $-21M | $-28M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $103.0K | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $65M | $85M | $138M | $-13M | $-11M | $-13M | $20M | $-32M | $-2.00B | $-12M | $346.0K | $-37M | $13M | $4M | $-2M | $-14M | |
| Net Change in Cash | $521M | $363M | $643M | $500M | $13M | $254M | $384M | $317M | $-2.36B | $133M | $-14M | $96M | $310M | $-130M | $261M | $255M | |
| Taxes Paid | $15M | $-9M | $27M | $7M | $177M | $844.0K | $70M | $73M | $227M | $3M | $125M | $116M | $130M | $7M | $20M | $40M |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.7% | 23.7% | · | 32.5% | 43.6% | 19.5% | · | 12.8% | -45.8% | 10.4% | · | 23.4% | 20.3% | 3.1% | · | 16.8% | |
| Net Margin | 35.0% | 23.8% | · | 31.1% | 33.3% | 15.0% | · | 9.4% | -42.6% | 19.2% | · | 18.6% | 21.3% | 2.7% | · | 13.7% | |
| Pretax Margin | 44.9% | 27.0% | · | 35.3% | 45.9% | 22.2% | · | 13.8% | -37.3% | 26.8% | · | 25.4% | 29.1% | 6.4% | · | 18.1% | |
| EBITDA Margin | 41.7% | 25.5% | · | 32.5% | 43.6% | 21.6% | · | 12.8% | -45.8% | 12.9% | · | 23.4% | 20.3% | 5.4% | · | 16.8% | |
| ROA | 8.6% | 4.6% | · | 7.5% | 7.7% | 2.5% | · | 1.9% | -8.2% | 2.6% | · | 2.9% | 3.5% | 0.40% | · | 2.3% | |
| ROE | 11.1% | 6.5% | · | 10.8% | 11.3% | 3.5% | · | 2.6% | -11.5% | 3.4% | · | 3.7% | 4.6% | 0.52% | · | 3.1% | |
| ROIC | 8.6% | 4.7% | · | 8.4% | 9.2% | 3.8% | · | 3.1% | -18.2% | 1.2% | · | 3.2% | 3.0% | 0.23% | · | 2.5% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.7 | · | 3.2 | 2.8 | 2.0 | · | 1.9 | 1.9 | 3.5 | · | 3.9 | 3.8 | 3.9 | · | 3.8 | |
| Quick Ratio | 3.0 | 2.3 | · | 1.8 | 1.5 | 1.1 | · | 0.9 | 0.7 | 2.4 | · | 2.9 | 2.8 | 2.8 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 213.7 | · | 344.6 | 295.8 | 52.8 | · | 215.9 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 1.1 | 1.2 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.1 | 1.2 | · | 1.2 | 1.5 | 1.5 | · | 1.6 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $31.57 | $28.12 | · | $23.71 | $21.49 | $18.93 | · | $16.45 | $15.64 | $24.02 | · | $22.01 | $21.23 | $20.01 | · | $19.00 | |
| Revenue / Share | $8.04 | $6.15 | · | $6.78 | $6.12 | $5.31 | · | $5.81 | $4.78 | $3.88 | · | $4.06 | $4.23 | $3.58 | · | $3.67 | |
| Cash Flow / Share | · | $1.79 | · | · | · | $1.34 | · | · | · | $0.96 | · | · | · | $-0.47 | · | · | |
| Cash / Share | $19.82 | $17.31 | · | $12.52 | $10.07 | $10.02 | · | $6.76 | $5.15 | $14.90 | · | $14.40 | $14.02 | $12.65 | · | $12.10 | |
| EPS (TTM) | $7.85 | $7.08 | · | $5.85 | $4.28 | $0.20 | · | $0.14 | $0.36 | $3.30 | · | $1.89 | $1.63 | $1.45 | · | $3.93 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.82B | $5.36B | · | $4.81B | $4.58B | $4.41B | · | $4.08B | $3.86B | $3.77B | · | $3.61B | $3.51B | $3.47B | · | $3.33B | |
| Net Income TTM | $1.61B | $1.43B | · | $1.19B | $871M | $21M | · | $32M | $97M | $745M | · | $425M | $366M | $324M | · | $876M | |
| Market Cap | $22.78B | $18.82B | · | $16.63B | $13.22B | $11.73B | · | $12.74B | $11.61B | $12.79B | · | $12.95B | $13.90B | $16.12B | · | $14.82B | |
| P/E | 14.4 | 13.3 | · | 14.5 | 15.9 | 302.8 | · | 472.1 | 168.4 | 17.3 | · | 30.6 | 38.2 | 49.8 | · | 17.0 | |
| P/S | 3.9 | 3.5 | · | 3.5 | 2.9 | 2.7 | · | 3.1 | 3.0 | 3.4 | · | 3.6 | 4.0 | 4.6 | · | 4.5 | |
| P/B | 3.6 | 3.3 | · | 3.6 | 3.2 | 3.2 | · | 4.0 | 3.9 | 2.4 | · | 2.6 | 2.9 | 3.6 | · | 3.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 3.7 | 3.3 | 3.3 | · | 4.2 | 4.1 | 2.4 | · | 2.7 | 3.0 | 3.7 | · | 3.6 | |
| P / Cash Flow | · | 51.0 | · | · | · | 44.1 | · | · | · | 58.5 | · | · | · | -152.7 | · | · | |
| Earnings Yield | 6.9% | 7.5% | · | 6.9% | 6.3% | 0.33% | · | 0.21% | 0.59% | 5.8% | · | 3.3% | 2.6% | 2.0% | · | 5.9% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| परिचालन मार्जिन % | 29.5% | 1.5% | · | 17.1% | 19.6% |
| शुद्ध आय | $1.29B | $33M | $598M | $341M | $949M |
| तनुकरणित EPS | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 3.3 | 2.0 | · | 3.5 | 3.7 |
| त्वरित अनुपात | 2.0 | 1.0 | · | 2.6 | 2.4 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | · | · | · | $892M | $568M |
संस्थागत मालिक (13F) 919 फाइलर्स · $24.0B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
919
धारित मूल्य
$24.0B
नई स्थितियाँ
123
बाहर निकली पोजीशन
68
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 123 (-4 पिछली तिमाही की तुलना में) | 68 (-29 पिछली तिमाही की तुलना में) | 356 (+47 पिछली तिमाही की तुलना में) | 274 (-17 पिछली तिमाही की तुलना में) | +1.4M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $3487217729 | 30762330 | 14.52% | शेयर |
| BlackRock, Inc. | $2044188907 | 18032718 | 8.51% | शेयर |
| VANGUARD GROUP INC | $1966652336 | 19911434 | 8.19% | शेयर |
| Dodge & Cox | $1355482475 | 11957326 | 5.64% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $1249713401 | 11024289 | 5.20% | शेयर |
| STATE STREET CORP | $1102124009 | 9722336 | 4.59% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $883198076 | 7791091 | 3.68% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $603177347 | 5320901 | 2.51% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $536515860 | 4750735 | 2.23% | शेयर |
| Invesco Ltd. | $462561060 | 4080461 | 1.93% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $405321059 | 3575521 | 1.69% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $398135284 | 3512132 | 1.66% | शेयर |
| MORGAN STANLEY | $334226735 | 2948364 | 1.39% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $311168439 | 2744958 | 1.30% | शेयर |
| Robeco Institutional Asset Management B.V. | $276795075 | 2441735 | 1.15% | शेयर |
| GOLDMAN SACHS GROUP INC | $261383430 | 2305782 | 1.09% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $258591850 | 2280803 | 1.08% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $227123448 | 2003559 | 0.95% | शेयर |
| NORTHERN TRUST CORP | $199736467 | 1761966 | 0.83% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $191854885 | 1692439 | 0.80% | शेयर |
| Legal & General Group Plc | $182053894 | 1605980 | 0.76% | शेयर |
| FIRST TRUST ADVISORS LP | $180015041 | 1587996 | 0.75% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $167811569 | 1480342 | 0.70% | शेयर |
| FMR LLC | $156637793 | 1381773 | 0.65% | शेयर |
| Caisse de depot et placement du Quebec | $155360220 | 1370503 | 0.65% | शेयर |
| MARSHALL WACE, LLP | $148519056 | 1310154 | 0.62% | शेयर |
| HSBC HOLDINGS PLC | $148336065 | 1307743 | 0.62% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $145030732 | 1540913 | 0.60% | शेयर |
| DEUTSCHE BANK AG\ | $143172320 | 1262988 | 0.60% | शेयर |
| AustralianSuper Pty Ltd | $135634220 | 1196491 | 0.56% | शेयर |
| Amundi | $133934668 | 1181498 | 0.56% | शेयर |
| ROYAL BANK OF CANADA | $128327000 | 1132050 | 0.53% | शेयर |
| NORGES BANK | $126861970 | 1119107 | 0.53% | शेयर |
| Bank of New York Mellon Corp | $110279448 | 972825 | 0.46% | शेयर |
| Man Group plc | $108025392 | 952941 | 0.45% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $106959694 | 943540 | 0.45% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $106304813 | 937763 | 0.44% | शेयर |
| ARMISTICE CAPITAL, LLC | $102024567 | 900005 | 0.42% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $99970937 | 881889 | 0.42% | शेयर |
| JPMORGAN CHASE & CO | $87335467 | 761690 | 0.36% | शेयर |
| UBS Group AG | $87051865 | 767924 | 0.36% | शेयर |
| Sound Shore Management Inc /CT/ | $85895479 | 757723 | 0.36% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $82953901 | 731774 | 0.35% | शेयर |
| Gotham Asset Management, LLC | $81567621 | 719545 | 0.34% | शेयर |
| Pictet Asset Management Holding SA | $81315880 | 713354 | 0.34% | शेयर |
| BANK OF AMERICA CORP /DE/ | $76653013 | 676191 | 0.32% | शेयर |
| MACKENZIE FINANCIAL CORP | $71967956 | 634862 | 0.30% | शेयर |
| CITIGROUP INC | $66477819 | 586431 | 0.28% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $65633852 | 578986 | 0.27% | शेयर |
| FRANKLIN RESOURCES INC | $63330037 | 558663 | 0.26% | शेयर |
कार्यकर्ता और 5%+ मालिक 7 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 फाइलिंग | 11 मई 2026 | 15.60% | संशोधन | निष्क्रिय निवेश | SEC |
| Incyte Corporation ×3 फाइलिंग | 14 अगस्त 2023 | · | प्रारंभिक फाइलिंग | पूंजी संरचना | SEC |
| Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 फाइलिंग | 15 जून 2012 | · | प्रारंभिक फाइलिंग | · | SEC |
| Julian C. Baker, Felix J. Baker ×12 फाइलिंग | 1 अक्टूबर 2009 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 25 फ़रवरी 2004 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 29 सितमबर 2003 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 15 अगस्त 2002 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 61 इनसाइडर्स · 34 अधिकारी · 17 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| William Meury | Chief Executive Officer | 16 जुलाई 2026 A | 183129 | 0 | 0 | $0 |
| Suketu Upadhyay | EVP & Chief Financial Officer | 4 मई 2026 A | 26343 | 0 | 0 | $0 |
| Christiana Stamoulis | EVP & Chief Financial Officer | 15 जुलाई 2025 A | 125759 | 0 | 0 | $0 |
| David W Gryska | Executive Vice President, CFO | 16 जुलाई 2018 F | 10235 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 5 जून 2014 M | 8500 | 0 | 0 | $0 |
| Pablo J Cagnoni | President, Global Head of R&D | 15 सितमबर 2026 M | 183200 | 0 | 9 | $-14102143 |
| David H Gardner | EVP, Chief Strategy Officer | 22 सितमबर 2026 F | 15904 | 0 | 0 | $0 |
| Ramitpal K Basi | EVP, Human Resources | 25 अगस्त 2026 F | 10993 | 0 | 0 | $0 |
| Patrick A Mayes | EVP & Chief Scientific Officer | 5 अगस्त 2026 M | 61441 | 0 | 15 | $-6562989 |
| Lee Heeson | EVP, Head of Incyte Intl | 23 जुलाई 2026 A | 38041 | 0 | 1 | $-289017 |
| Michael James Morrissey | EVP, Head of Tech. Operations | 23 जुलाई 2026 A | 34065 | 0 | 3 | $-5675002 |
| Richard A. Hoffman | EVP & General Counsel | 16 जुलाई 2026 A | 16861 | 0 | 0 | $0 |
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 16 जुलाई 2026 A | 71797 | 0 | 2 | $-1309770 |
| Thomas Tray | Principal Accounting Officer | 16 जुलाई 2026 A | 21699 | 0 | 6 | $-878953 |
| Steven H Stein | CMO & Head of Late-Stage Dev. | 16 जुलाई 2026 A | 30916 | 0 | 6 | $-7856771 |
| Matteo Trotta | EVP, GM, Dermatology US | 25 मार्च 2026 F | 14882 | 0 | 0 | $0 |
| Sheila A. Denton | EVP & General Counsel | 17 नवमबर 2025 M | 26569 | 0 | 5 | $-465184 |
| Vijay K Iyengar | EVP, GMAPPS | 16 जुलाई 2025 S | 40540 | 0 | 0 | $0 |
| Barry P Flannelly | EVP & General Manager US | 16 जुलाई 2025 S | 35149 | 0 | 0 | $0 |
| Paula J Swain | EVP, Human Resources | 15 जुलाई 2025 A | 106482 | 0 | 0 | $0 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | 12 सितमबर 2024 S | 36390 | 0 | 0 | $0 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | 14 जुलाई 2023 A | 58968 | 0 | 0 | $0 |
| Maria E Pasquale | EVP & General Counsel | 14 जुलाई 2023 A | 69724 | 0 | 0 | $0 |
| Paul Trower | Principal Accounting Officer | 19 जनवरी 2022 A | 32268 | 0 | 0 | $0 |
| Yao Wenqing | EVP, Head of Discovery Chem | 2 जुलाई 2021 A | 98575 | 0 | 0 | $0 |
| Reid M Huber | EVP, Chief Scientific Officer | 16 जुलाई 2018 F | 34571 | 0 | 0 | $0 |
| Eric H. Siegel | EVP, General Counsel | 13 सितमबर 2017 F | 21053 | 0 | 0 | $0 |
| Richard S Levy | EVP, Chief Drug Dev Officer | 6 जनवरी 2016 M | 16926 | 0 | 0 | $0 |
| James M Daly | EVP, Chief Commercial Officer | 23 जून 2015 M | 3521 | 0 | 0 | $0 |
| Patricia S Andrews | Chief Commercial Officer | 19 जनवरी 2012 A | · | 0 | 0 | $0 |
| Patricia A Schreck | EVP, General Counsel | 10 मई 2011 M | 4500 | 0 | 0 | $0 |
| Brian W Metcalf | Chief Drug Discovery Scientist | 11 अप्रैल 2011 M | 66504 | 0 | 0 | $0 |
| Steven M. Friedman | EVP, Biology & Preclinical Dev | 18 मई 2010 A | 38137 | 0 | 0 | $0 |
| John A Keller | Chief Business Officer | 8 फ़रवरी 2008 A | · | 0 | 0 | $0 |
| Paul J Clancy | निदेशक | 30 सितमबर 2026 A | 25838 | 0 | 1 | $-1423950 |
| Edmund Harrigan | निदेशक | 30 सितमबर 2026 A | 23225 | 0 | 0 | $0 |
| Katherine A High | निदेशक | 8 जून 2026 A | 14983 | 0 | 0 | $0 |
| Jacqualyn A Fouse | निदेशक | 8 जून 2026 A | 20968 | 0 | 0 | $0 |
| Jean Jacques Bienaime | निदेशक | 8 जून 2026 A | 24424 | 0 | 0 | $0 |
| Otis W Brawley | निदेशक | 8 जून 2026 A | 12894 | 0 | 0 | $0 |
| Herve Hoppenot | निदेशक | 8 दिसमबर 2025 F | 326803 | 0 | 1 | $-19773750 |
| Susanne Schaffert | निदेशक | 10 जून 2025 A | 7389 | 0 | 0 | $0 |
| Wendy L Dixon | निदेशक | 31 मार्च 2022 A | 17768 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | निदेशक | 26 मई 2020 A | 256813 | 0 | 0 | $0 |
| Paul A Brooke | निदेशक | 31 मार्च 2020 A | 221911 | 0 | 0 | $0 |
| Barry A Ariko | निदेशक | 12 मार्च 2015 M | 45834 | 0 | 0 | $0 |
| Richard U De Schutter | निदेशक | 5 मार्च 2015 M | 92290 | 0 | 0 | $0 |
| Roy A Whitfield | निदेशक | 17 दिसमबर 2013 M | 666082 | 0 | 0 | $0 |
| John F Niblack | निदेशक | 20 मई 2011 A | · | 0 | 0 | $0 |
| Fred B Craves | निदेशक | 1 जून 2005 A | 196793 | 0 | 0 | $0 |
| DAMIAL FOUNDATION INC | 10% मालिक | 11 फ़रवरी 2004 S | · | 0 | 0 | $0 |
| Bonnie J Tisch | 10% मालिक | 14 जनवरी 2004 S | · | 0 | 0 | $0 |
| Laurent Chardonnet | · | 30 मार्च 2015 M | 2905 | 0 | 0 | $0 |
| Julian C. Baker | · | 30 मई 2013 A | 66340 | 0 | 0 | $0 |
| Matthew Emmens | · | 22 मई 2008 A | · | 0 | 0 | $0 |
| HURLEY SCOTT W | · | 19 जनवरी 2005 A | · | 0 | 0 | $0 |
| Daniel R Tisch | · | 12 अगस्त 2004 P | 1216661 | 0 | 0 | $0 |
| TISCH THOMAS J | · | 12 अगस्त 2004 P | 1416661 | 0 | 0 | $0 |
| James S Tisch | · | 12 अगस्त 2004 P | 1216661 | 0 | 0 | $0 |
| Andrew H Tisch | · | 12 अगस्त 2004 P | 1216661 | 0 | 0 | $0 |
| Jon S Saxe | · | 30 मार्च 2004 M | 80000 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 149 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IDNA · iShares Trust | 3.73% | 77294 SH | 11 सितमबर 2026 | दैनिक |
| SAWG · ETF Series Solutions | 3.28% | 792 NS | 31 जुलाई 2026 | N-PORT |
| BUL · Pacer Funds Trust | 3.05% | 33574 NS | 31 जुलाई 2026 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 2.55% | 90459 SH | 2 अक्टूबर 2026 | दैनिक |
| SMRI · EA Series Trust | 2.07% | 111793 NS | 31 जुलाई 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1.99% | 344 NS | 31 जुलाई 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 1.94% | 27325 SH | 2 अक्टूबर 2026 | दैनिक |
| UPGD · Invesco Exchange-Traded Fund Trust | 1.90% | 18656 SH | 2 अक्टूबर 2026 | दैनिक |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.86% | 323409 SH | 2 अक्टूबर 2026 | दैनिक |
| IBB · iShares Trust | 1.81% | 1512762 SH | 11 सितमबर 2026 | दैनिक |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.80% | 10419 NS | 31 जुलाई 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.78% | 156306 NS | 31 जुलाई 2026 | N-PORT |
| RPG · Invesco Exchange-Traded Fund Trust | 1.63% | 270969 SH | 2 अक्टूबर 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1.59% | 14343 SH | 2 अक्टूबर 2026 | दैनिक |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.54% | 114153 SH | 2 अक्टूबर 2026 | दैनिक |
| BBP · ETFis Series Trust I | 1.52% | 12506 NS | 31 जुलाई 2026 | N-PORT |
| CALF · Pacer Funds Trust | 1.52% | 465439 NS | 31 जुलाई 2026 | N-PORT |
| GURU · Global X Funds | 1.37% | 7010 NS | 31 जुलाई 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1.19% | 119789 SH | 2 अक्टूबर 2026 | दैनिक |
| LSVD · ADVISORS' INNER CIRCLE FUND | 1.04% | 56481 NS | 31 जुलाई 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 1.03% | 113368 NS | 31 जुलाई 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.82% | 9194 SH | 2 अक्टूबर 2026 | दैनिक |
| INFO · Harbor ETF Trust | 0.81% | 57450 NS | 31 जुलाई 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.77% | 992 NS | 31 जुलाई 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.77% | 32018 NS | 31 जुलाई 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0.73% | 14779 NS | 31 जुलाई 2026 | N-PORT |
| COWG · Pacer Funds Trust | 0.72% | 132772 NS | 31 जुलाई 2026 | N-PORT |
| BRNY · EA Series Trust | 0.57% | 27866 NS | 31 जुलाई 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0.56% | 70403 SH | 2 अक्टूबर 2026 | दैनिक |
| ESMV · iShares Trust | 0.54% | 339 SH | 11 सितमबर 2026 | दैनिक |
| VBK · VANGUARD INDEX FUNDS | 0.53% | 2249253 SH | 19 अगस्त 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.51% | 24639 NS | 31 जुलाई 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0.50% | 774539 NS | 31 जुलाई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.49% | 29166 NS | 31 जुलाई 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0.49% | 2011 NS | 31 जुलाई 2026 | N-PORT |
| TECB · iShares Trust | 0.49% | 19516 SH | 11 सितमबर 2026 | दैनिक |
| VLLU · Harbor ETF Trust | 0.49% | 189 NS | 31 जुलाई 2026 | N-PORT |
| USMV · iShares Trust | 0.47% | 910173 SH | 11 सितमबर 2026 | दैनिक |
| VFQY · VANGUARD WELLINGTON FUND | 0.46% | 19147 SH | 19 अगस्त 2026 | दैनिक |
| ESLV · Strategy Shares | 0.45% | 537 NS | 31 जुलाई 2026 | N-PORT |
| SDG · iShares Trust | 0.42% | 5697 SH | 11 सितमबर 2026 | दैनिक |
| ACWV · iShares, Inc. | 0.41% | 111137 SH | 11 सितमबर 2026 | दैनिक |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.39% | 15107 NS | 31 जुलाई 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.38% | 49720 NS | 31 जुलाई 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.35% | 72339 NS | 31 जुलाई 2026 | N-PORT |
| IYH · iShares Trust | 0.33% | 97043 SH | 11 सितमबर 2026 | दैनिक |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.32% | 12427 NS | 31 जुलाई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.29% | 80584 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.28% | 508499 SH | 19 अगस्त 2026 | दैनिक |
| VFMF · VANGUARD WELLINGTON FUND | 0.27% | 16793 SH | 19 अगस्त 2026 | दैनिक |
| IXJ · iShares Trust | 0.26% | 88044 SH | 11 सितमबर 2026 | दैनिक |
| SIZE · iShares Trust | 0.25% | 8715 SH | 11 सितमबर 2026 | दैनिक |
| FBUF · Fidelity Greenwood Street Trust | 0.25% | 498 NS | 31 जुलाई 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 0.24% | 997 NS | 31 जुलाई 2026 | N-PORT |
| LGDX · Tidal Trust III | 0.23% | 2756 NS | 31 जुलाई 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.23% | 3894602 SH | 19 अगस्त 2026 | दैनिक |
| CURE · Direxion Shares ETF Trust | 0.23% | 3302 NS | 31 जुलाई 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.22% | 437 NS | 31 जुलाई 2026 | N-PORT |
| IWS · iShares Trust | 0.20% | 247446 SH | 11 सितमबर 2026 | दैनिक |
| EUSA · iShares, Inc. | 0.20% | 30370 SH | 11 सितमबर 2026 | दैनिक |
| RSP · Invesco Exchange-Traded Fund Trust | 0.19% | 1548872 SH | 2 अक्टूबर 2026 | दैनिक |
| FTLS · First Trust Exchange-Traded Fund III | 0.19% | 38962 NS | 31 जुलाई 2026 | N-PORT |
| FHEQ · Fidelity Greenwood Street Trust | 0.18% | 13826 NS | 31 जुलाई 2026 | N-PORT |
| IMCV · iShares Trust | 0.17% | 16093 SH | 11 सितमबर 2026 | दैनिक |
| VFMO · VANGUARD WELLINGTON FUND | 0.17% | 30550 SH | 19 अगस्त 2026 | दैनिक |
| ESUM · Strategy Shares | 0.16% | 2509 NS | 31 जुलाई 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0.16% | 260988 SH | 2 अक्टूबर 2026 | दैनिक |
| DFLV · Dimensional ETF Trust | 0.16% | 91827 NS | 31 जुलाई 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.16% | 12315 SH | 19 अगस्त 2026 | दैनिक |
| ESLG · Strategy Shares | 0.16% | 307 NS | 31 जुलाई 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0.16% | 106670 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.15% | 678309 SH | 11 सितमबर 2026 | दैनिक |
| IMCB · iShares Trust | 0.14% | 19540 SH | 11 सितमबर 2026 | दैनिक |
| EVUS · iShares Trust | 0.12% | 3715 SH | 11 सितमबर 2026 | दैनिक |
| XOEF · iShares Trust | 0.12% | 213 SH | 11 सितमबर 2026 | दैनिक |
| IMCG · iShares Trust | 0.12% | 37577 SH | 11 सितमबर 2026 | दैनिक |
| DFUV · Dimensional ETF Trust | 0.11% | 146271 NS | 31 जुलाई 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.10% | 19945 NS | 31 जुलाई 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.10% | 41885 SH | 2 अक्टूबर 2026 | दैनिक |
| ESGU · iShares Trust | 0.10% | 141033 SH | 11 सितमबर 2026 | दैनिक |
| CATH · Global X Funds | 0.10% | 10371 NS | 31 जुलाई 2026 | N-PORT |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0.09% | 180160 SH | 2 अक्टूबर 2026 | दैनिक |
| DXUV · Dimensional ETF Trust | 0.09% | 4162 NS | 31 जुलाई 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 6132 SH | 2 अक्टूबर 2026 | दैनिक |
| USXF · iShares Trust | 0.08% | 10050 SH | 11 सितमबर 2026 | दैनिक |
| PALC · Pacer Funds Trust | 0.08% | 1398 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.08% | 21901 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.07% | 298392 NS | 31 जुलाई 2026 | N-PORT |
| GARP · iShares Trust | 0.07% | 17562 SH | 11 सितमबर 2026 | दैनिक |
| SUSL · iShares Trust | 0.06% | 6008 SH | 11 सितमबर 2026 | दैनिक |
| CHRI · Global X Funds | 0.06% | 41 NS | 31 जुलाई 2026 | N-PORT |
| DSI · iShares Trust | 0.06% | 25952 SH | 11 सितमबर 2026 | दैनिक |
| IVW · iShares Trust | 0.06% | 354438 SH | 11 सितमबर 2026 | दैनिक |
| IUSG · iShares Trust | 0.06% | 147395 SH | 11 सितमबर 2026 | दैनिक |
| IWD · iShares Trust | 0.05% | 367740 SH | 11 सितमबर 2026 | दैनिक |
| GLOF · iShares Trust | 0.05% | 840 SH | 11 सितमबर 2026 | दैनिक |
| VOOG · VANGUARD ADMIRAL FUNDS | 0.05% | 124582 SH | 19 अगस्त 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.05% | 100000 SH | 19 अगस्त 2026 | दैनिक |
| REVS · Columbia ETF Trust I | 0.05% | 1396 NS | 31 जुलाई 2026 | N-PORT |
| EGLE · Global X Funds | 0.05% | 9 NS | 31 जुलाई 2026 | N-PORT |
| HAPI · Harbor ETF Trust | 0.05% | 1975 NS | 31 जुलाई 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.05% | 38893 SH | 2 अक्टूबर 2026 | दैनिक |
| DFVX · Dimensional ETF Trust | 0.05% | 1993 NS | 31 जुलाई 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.04% | 3572 SH | 2 अक्टूबर 2026 | दैनिक |
| DFAU · Dimensional ETF Trust | 0.04% | 43168 NS | 31 जुलाई 2026 | N-PORT |
| TOV · EA Series Trust | 0.04% | 910 NS | 31 जुलाई 2026 | N-PORT |
| TOPC · iShares Trust | 0.04% | 100 SH | 11 सितमबर 2026 | दैनिक |
| ILCV · iShares Trust | 0.04% | 3819 SH | 11 सितमबर 2026 | दैनिक |
| XVV · iShares Trust | 0.04% | 1907 SH | 11 सितमबर 2026 | दैनिक |
| XYLG · Global X Funds | 0.03% | 186 NS | 31 जुलाई 2026 | N-PORT |
| XCLR · Global X Funds | 0.03% | 10 NS | 31 जुलाई 2026 | N-PORT |
| XRMI · Global X Funds | 0.03% | 133 NS | 31 जुलाई 2026 | N-PORT |
| IVV · iShares Trust | 0.03% | 2115770 SH | 11 सितमबर 2026 | दैनिक |
| XYLD · Global X Funds | 0.03% | 8564 NS | 31 जुलाई 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.03% | 4458 SH | 2 अक्टूबर 2026 | दैनिक |
| PTLC · Pacer Funds Trust | 0.03% | 8472 NS | 31 जुलाई 2026 | N-PORT |
| ILCB · iShares Trust | 0.03% | 3242 SH | 11 सितमबर 2026 | दैनिक |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.03% | 22989 NS | 31 जुलाई 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.03% | 2822 NS | 31 जुलाई 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.03% | 1013 SH | 2 अक्टूबर 2026 | दैनिक |
| BKLC · BNY Mellon ETF Trust | 0.03% | 13892 NS | 31 जुलाई 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.03% | 29419 SH | 2 अक्टूबर 2026 | दैनिक |
| VOO · VANGUARD INDEX FUNDS | 0.03% | 4357457 SH | 19 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.03% | 5391866 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.03% | 27427 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.03% | 13959 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.03% | 37474 SH | 19 अगस्त 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.03% | 51979 NS | 31 जुलाई 2026 | N-PORT |
| XTR · Global X Funds | 0.03% | 12 NS | 31 जुलाई 2026 | N-PORT |
| IWB · iShares Trust | 0.03% | 114458 SH | 11 सितमबर 2026 | दैनिक |
| IYY · iShares Trust | 0.03% | 7092 SH | 11 सितमबर 2026 | दैनिक |
| SPUU · Direxion Shares ETF Trust | 0.03% | 634 NS | 31 जुलाई 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.03% | 4037 NS | 31 जुलाई 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0.03% | 95298 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.03% | 45601 SH | 11 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.03% | 215857 SH | 11 सितमबर 2026 | दैनिक |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.03% | 23005 SH | 2 अक्टूबर 2026 | दैनिक |
| ACVF · ETF Opportunities Trust | 0.03% | 345 NS | 31 जुलाई 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0.03% | 13186 NS | 31 जुलाई 2026 | N-PORT |
| ILCG · iShares Trust | 0.03% | 6647 SH | 11 सितमबर 2026 | दैनिक |
| PHDG · Invesco Actively Managed Exchange-T… | 0.03% | 133 SH | 2 अक्टूबर 2026 | दैनिक |
| TOK · iShares Trust | 0.03% | 485 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.03% | 4582 NS | 31 जुलाई 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0.02% | 1167 NS | 31 जुलाई 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.02% | 13118 NS | 31 जुलाई 2026 | N-PORT |
| URTH · iShares, Inc. | 0.02% | 14482 SH | 11 सितमबर 2026 | दैनिक |
| ACWI · iShares Trust | 0.02% | 55495 SH | 11 सितमबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 142324 SH | 19 अगस्त 2026 | दैनिक |
| CRBN · iShares Trust | 0.01% | 876 SH | 11 सितमबर 2026 | दैनिक |
INCY विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 35 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$130.00
+12.7%
8 22.9%
मजबूत खरीद
10 28.6%
खरीदें
17 48.6%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
23 विश्लेषक · 2026-09-29माध्य लक्ष्य $127.96 +11.0%
अभी
वर्तमान मूल्य $115.30
निम्न$86.00
माध्य$127.96
उच्च$155.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | · |
| RVMD | · | · | · | · | · | · |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | · |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | · |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | · |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | · |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | · |
| SMMT | $13.56B | -12.1 | · | · | -235.1% | · |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | · |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
BLUECHIP_DIP
स्टॉप आउट
जोखिम 1
पुरस्कार 5.00
प्रवेश
$95.85
R:R 5.00
BLUECHIP_DIP
समाप्त
जोखिम 1
पुरस्कार 5.00
प्रवेश
$95.27
R:R 5.00
BLUECHIP_DIP
समाप्त
जोखिम 1
पुरस्कार 1.30
प्रवेश
$91.77
R:R 1.30
अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q जुल 28, 2026 को फाइल किया गया